Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (661-670 of 676) with videos related to

Pageof 68
Sort By:
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 25, 2014
Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin diseaseSusanne Karbach, Andrew L Croxford, Matthias Oelze, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
Nature Communications|July 26, 2020
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionDavid Simon, Koray Tascilar, Gerhard Krönke, et al.
Gut|August 4, 2023
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cellsKaren Anne-Marie Ullrich, Julia Derdau, Carsten Baltes, et al.
BMJ Open|January 8, 2025
Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseasesMelek Yalcin Mutlu, Arnd Kleyer, Gerhard Kroenke, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 12, 2026
Coordinated IFN-γ/TNF Axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel DiseasesMarvin Bubeck, Klara A Penkert, Heidi Limberger, et al.
Gut|March 4, 2022
Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammationLuz Del Carmen Martínez-Sánchez, Phuong Anh Ngo, Rashmita Pradhan, et al.
Journal of Crohn'S & Colitis|March 27, 2021
Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s DiseaseCorinna Lang-Schwarz, Miriam Angeloni, Abbas Agaimy, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 30, 2026
Early gut-vascular barrier breakdown precedes colitis onset in murine modelsMariam Mohamed Abdou, Lucas Kreiß, Benjamin Schmid, et al.
Pageof 68

Showing results (661-670 of 676) with videos related to

Sort By:
Pageof 68
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 25, 2014
Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin diseaseSusanne Karbach, Andrew L Croxford, Matthias Oelze, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
Nature Communications|July 26, 2020
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionDavid Simon, Koray Tascilar, Gerhard Krönke, et al.
Gut|August 4, 2023
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cellsKaren Anne-Marie Ullrich, Julia Derdau, Carsten Baltes, et al.
BMJ Open|January 8, 2025
Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseasesMelek Yalcin Mutlu, Arnd Kleyer, Gerhard Kroenke, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 12, 2026
Coordinated IFN-γ/TNF Axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel DiseasesMarvin Bubeck, Klara A Penkert, Heidi Limberger, et al.
Gut|March 4, 2022
Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammationLuz Del Carmen Martínez-Sánchez, Phuong Anh Ngo, Rashmita Pradhan, et al.
Journal of Crohn'S & Colitis|March 27, 2021
Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s DiseaseCorinna Lang-Schwarz, Miriam Angeloni, Abbas Agaimy, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 30, 2026
Early gut-vascular barrier breakdown precedes colitis onset in murine modelsMariam Mohamed Abdou, Lucas Kreiß, Benjamin Schmid, et al.
Pageof 68